Group 1 - The core viewpoint is that Celestica's (CLS) strong Q4 2024 results led to a slight downgrade in rating from Strong Buy to Buy due to rapid price increase and anticipated negative seasonality [1] - Bram de Haas, with 15 years of investing experience and over 5 years managing a Euro hedge fund, is highlighted for his risk management skills and ability to identify lucrative investments [1]

Group 1 - Celestica is positioned as a key player in the AI and cloud infrastructure sectors, benefiting from the increasing demand from hyperscalers [1] - The company serves as a profit-leveraged enabler for backbone systems, indicating its critical role in supporting the growth of these technologies [1] Group 2 - The investment strategy of the analyst focuses on long-term fundamentals and valuation discipline, particularly in technology, semiconductors, AI, and energy sectors [1] - The analyst manages a long-only, unleveraged portfolio aimed at capital preservation and capturing asymmetric upside during market dislocations [1] - The Nasdaq High-Alpha Black Swan Portfolio is highlighted as a private strategy designed for resilience and long-term outperformance [1]

Core Viewpoint - Celestica (CLS) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [3][5]. - Institutional investors often adjust their valuations based on earnings estimates, leading to significant stock price movements when estimates are revised [3]. Celestica's Earnings Outlook - Celestica is projected to earn $5.05 per share for the fiscal year ending December 2025, reflecting a year-over-year increase of 30.2% [7]. - Over the past three months, the Zacks Consensus Estimate for Celestica has risen by 1.7%, indicating a positive trend in earnings expectations [7]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [6]. - The upgrade of Celestica to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [9].

Celestica Inc. (CLS) has gained 98.8% over the past year compared with the industry’s growth of 36.4%. It has also outperformed peers like Flex Ltd. (FLEX) and Jabil Inc. (JBL) . Flex has gained 26.7% and Jabil is up 25.9% over this period.  Celestica boasts a diverse portfolio of products that are integral to AI (artificial intelligence) applications. With more than 25 years of experience in manufacturing backed by a simplified and optimized global network, it is committed to delivering next-generation, cl ...

Shares of Celestica (CLS) have gained 28.9% over the past four weeks to close the last trading session at $89.21, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $120 indicates a potential upside of 34.5%.The average comprises 10 short-term price targets ranging from a low of $95 to a high of $150, with a standard deviation of $13.85. While the lowest estimate indicates an incre ...

Group 1 - Celestica (CLS) has recently reached a key level of support and has overtaken the 50-day moving average, indicating a short-term bullish trend [1] - CLS has rallied 28.9% over the past four weeks and currently holds a Zacks Rank 2 (Buy), suggesting potential for further upward movement [2] - Positive earnings estimate revisions for CLS, with three higher estimates compared to none lower for the current fiscal year, strengthen the bullish outlook [2] Group 2 - Investors are encouraged to monitor CLS for potential gains in the near future due to its key technical level and favorable earnings revisions [3]

Core Insights - The Q1 2025 earnings cycle is heavily focused on guidance, influenced by recent economic uncertainties and tariff announcements [1][9] - Several companies, including Centene, Boston Scientific, and Celestica, have raised their guidance, indicating positive performance [2][17] Centene (CNC) - Centene reported an adjusted EPS of $2.90 and sales of $46.6 billion, exceeding consensus estimates with a year-over-year earnings growth of 28% [3] - The company raised its 2025 premium and service revenues guidance by $6.0 billion, reflecting a 17% year-over-year improvement [3][6] - Analysts now expect Centene to post $172.8 billion in revenues for the current fiscal year, with a favorable Zacks Rank 2 (Buy) [6] Boston Scientific (BSX) - Boston Scientific surpassed both top and bottom line expectations, achieving a 12% EPS beat and sales 2.3% above expectations [8] - The company now anticipates FY25 sales growth between 15% and 17%, with current year sales expectations adjusted to $19.4 billion, a 10% increase from the previous year [10] Celestica (CLS) - Celestica exceeded Zacks Consensus EPS estimates by 8% and reported sales nearly 4% ahead of expectations, with a year-over-year sales growth of 20% [12] - The company raised its full-year 2025 revenue outlook to $10.85 billion from $10.7 billion, expecting non-GAAP adjusted EPS of $5.00, up from $4.75 [13] - Strong demand for solutions amid the AI trend and a shift to higher-margin products contributed to Celestica's stellar performance [13]

Celestica Inc CLS reported better-than-expected first-quarter earnings after the closing bell on Thursday.The company posted revenue of $2.65 billion, versus estimates of $2.61 billion. Adjusted earnings came in at $1.20 per share, versus estimates of $1.15 per share."Celestica delivered a strong first quarter in 2025, achieving revenue of $2.65 billion and non-GAAP adjusted EPS of $1.20, both surpassing the high end of our guidance ranges. This strong performance was further highlighted by our highest ever ...

Group 1 - The core focus of JR Research is on identifying attractive risk/reward opportunities that can generate alpha above the S&P 500 through robust price action [1][2] - The investment strategy emphasizes growth investing, combining price action analysis with fundamental investing while avoiding overhyped stocks [2] - JR Research runs the Ultimate Growth Investing group, which specializes in high-potential opportunities across various sectors with a 18 to 24 month outlook [3] Group 2 - The group targets growth stocks with strong fundamentals, buying momentum, and turnaround plays at attractive valuations [3] - JR Research has been recognized as a Top Analyst by TipRanks and Seeking Alpha for expertise in Technology, Software, Internet, Growth, and GARP [1]

Features of the group include: Insights through his concentrated portfolio of value stocks, timely updates on stock picks, a weekly webinar for live advice, and "hand-holding" as-needed for new and experienced investors alike. Deep Value Returns also has an active, vibrant, and kind community easily accessible via chat. Learn more Seeking FCF is an associate of Michael Wiggins De Oliveira Through his 10+ years analyzing countless companies, Michael has accumulated outstanding professional experience in tech ...